Hung Wei Chen
Chief Operating Officer presso LIN BIOSCIENCE, INC.
Profilo
Hung Wei Chen is currently the Chief Operating Officer & Director at Lin BioScience, Inc. and the Director at Belite Bio, Inc. Previously, she worked as the Associate Director-Clinical Development at CVie Therapeutics Ltd.
from 2015 to 2016, the Senior Manager-Clinical Operations at OBI Pharma, Inc. from 2012 to 2014, and the Manager-Project, Study & Clinical Operations at Pfizer Ltd.
(Taiwan) from 2005 to 2012.
She graduated from the National Taiwan University College of Medicine.
Posizioni attive di Hung Wei Chen
Società | Posizione | Inizio |
---|---|---|
LIN BIOSCIENCE, INC. | Chief Operating Officer | 01/08/2018 |
BELITE BIO, INC | Director/Board Member | 01/11/2021 |
Precedenti posizioni note di Hung Wei Chen
Società | Posizione | Fine |
---|---|---|
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Founded in 2013, CVie Therapeutics Ltd. is a subsidiary of Windtree Therapeutics, Inc. The private company is based in Taipei, Taiwan. The Taiwanese company develops and researches drugs. | Corporate Officer/Principal | 01/01/2016 |
OBI PHARMA, INC. | Corporate Officer/Principal | 01/01/2014 |
Pfizer Ltd. (Taiwan) | Corporate Officer/Principal | 01/01/2012 |
Formazione di Hung Wei Chen
National Taiwan University College of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
OBI PHARMA, INC. | Health Technology |
LIN BIOSCIENCE, INC. | Health Technology |
BELITE BIO, INC | Health Technology |
Aziende private | 2 |
---|---|
Pfizer Ltd. (Taiwan) | |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Founded in 2013, CVie Therapeutics Ltd. is a subsidiary of Windtree Therapeutics, Inc. The private company is based in Taipei, Taiwan. The Taiwanese company develops and researches drugs. | Health Technology |
- Borsa valori
- Insiders
- Hung Wei Chen